Chemistfrog
Long only, growth, momentum, contrarian

Recent Advaxis 10Q Deserves A Closer Look

Advaxis Inc (NASDAQ:ADXS) September 16th 10Q filing was apparently overlooked by many investors who were likely largely interested in financials such as cash burn rate, current cash levels, revenue and other pertinent facts. Such information is indeed important and relevant with regard to valuation and potential share price movement. However, the company is a development-phase entity whose real value lies in its near-term and longer term potential product line and associated targeted markets. While scanning through the filing I noticed details that I am honestly surprised haven't been announced independently via separate press releases. Before getting to those tidbits, I am pleasantly perplexed honestly that the company chose not to parade this information as many such development-phase companies...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details